[1] De Gaetano G. Historical over of the platelets in hemostasis and thrombosis [J]. Haematologica, 2001, 86(4): 349-356. [2] 吕毅,郝宝岚,王艳,等. 肿瘤患者血小板相关抗体分析[J].中国输血杂志, 2009, 22(5): 350-351. [3] 董伟群,郭萍,佟力. 血液病患者血小板无效输注的免疫因素探讨[J]. 中国输血杂志, 2009, 22 (4): 304-305. [4] 胡丽华. 检验与临床诊断分析[M]. 北京:人民军医出版社, 2009: 60-62. [5] Hod E, Schwartz. Platelet transfusion refractoriness[J]. BrHaematol, 2008,142 [6] (3): 348-360. [7] Rebulla P. Formulae for the definition of refractoriness to platelet transfusion[J]. Transfusion medicine, 1993, 3(1): 91-93. [8] 夏文杰. 血小板输血与血小板输注无效[A]. 基础输血学[M]. 北京:人民卫生出版社, 2011: 275-280. [9] 李勇, 马学严. 实用血液免疫学:血型理论和实验技术[M]. 北京:科学出版社, 2006: 297-301. [10] Vassallo RR. Recognition and management of antibodies to human plateletantigens in platelet transfusion-refractory patients[J]. Immunohematology, 2009, 25(3): 119-124. [11] Petz DL, Garratty G. Selecting donors of platelets for refractorypatientson the basis of HLA antibody specificity[J]. Transfusion, 2000, 40( 12) :1446-1456. [12] Ogata T. CD36 ( Naka) sensitization with platelet-transfusion refractoriness in a liver transplant recipient[J]. Transplantation, 2005, 79( 5) : 620. [13] Eisenberg S. Refractory response to platelet transfusion therapy[J]. J Infus Nurs, 2010, 33(2): 89-97. [14] 邓晶, 夏文杰, 叶欣,等. HLA抗体引起血小板输注无效的探讨[J]. 广东医学, 2010, 31(7): 861-862. [15] 胡维, 何巍巍, 胡志坚. 血小板抗体检测与患者血小板输注效果的分析[J].中国输血杂志, 2011, 24 (5): 427-428. [16] Dunbar NM,Ornstein DL,Dumont LJ. ABO incompatible platelets:risks versus benefit[J]. Curr Opin Hematol, 2012, 19(6): 475-479. [17] Daniel-Johnson J,Leitman S,Klein H, et al. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions[J]. Transfusion, 2009, 49(9): 1845-1849. [18] Slichter SJ,Davis K,Enright H,et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients[J]. Blood, 2005, 105(10): 4106-4114. [19] Hirano K,Kuwasako T,Nakagawa-Toyama Y,et al. Pathophysiology of human genetic CD36 deficiency[J]. Trends Cardiovasc Med, 2003, 13(4):136-141. [20] Yanai H,Chiba H,Fujiwara H,et al. Phenotype-genotype correlation in CD36 deficiency types Ⅰ and Ⅱ[J]. Thromb Haemost,2000,84( 3):436-441. [21] Ogata T. CD36 ( Naka) sensitization with platelet-transfusion refractoriness in a liver transplant recipient[J]. Transplantation, 2005,79(5):620. [22] 曹斯,张学元.广州首现CD36抗体引起血小板输注无效病例[N]. 南方日报, 2011-7-19(A09). [23] 周燕,李丽兰,钟周琳,等.南宁地区血小板输注无效患者血小板同种抗体检测及特异性分析[J]. 临床输血与检验, 2015,4(2):103-106. [24] Curtis BR,Aster RH.Incidence of the Nak a -negative platelet phenotype in African Americans is similar to that of Asians[J]. Transfusion, 1996, 36(4): 331-334. [25] 李大成,蓝欲晓,鲍自谦,等.深圳地区无偿献血者群体CD36 抗原缺失型的表型分析[J]. 中国输血杂志, 2012, 4 (4): 304-307. [26] Lucas G,Culliford S,Green F,et al. Recipient-derived HPA-1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation [J]. Transfusion, 2010, 50(2): 334-339. [27] Fabris F,Soini B,Sartori R,et al. Clinical and laboratory factors that affect the post transfusion platelet increment[J]. Transfus Sci, 2000, 23(1): 63-68. 1)Vassallo RR. Recognition and management of antibodies to human platelet antigens in platelet transfusion-refractory patients[J]. Immunohematology, 2009, 25( 3): 119-124. [28] Hauck-Dlimi B,Hammon K,Eckstein R,et al. Human platelet antigen genotypes in Turkish and Caucasian blood donors in Germany[J]. Tissue Antigens, 2012,80(3):214-218. [29] Pavkovic M,Stojanovic A,Karanfilski O, et al. Association of polymorphisms in human platelet antigens with idiopathic thrombocytopenic purpura in Macedonians[J]. Prilozi, 2012, 33(1): 135-146. [30] Asmarinah, Dharma R, Ritchie NK, et al. Human platelet-specific antigen frequencies in Indonesian population[J]. Transfus Med, 2013, 23(4): 250-253. [31] 杨波, 吕运来, 朱丽莉, 等. 洛阳地区献血员人类血小板抗原1~10频率分布调查[J]. 临床血液学杂志, 2014, 27(6): 464-467. [32] 周丹, 张印则, 庄乃保, 等. 2458名中国汉族人类HPA-1~6、15基因多态性的研究[J]. 中国输血杂志, 2012, 25(4): 300-303. [33] 廖燕, 申卫东, 李丽兰, 等. 广西壮族自治区壮族居民血小板抗原HPA-2 基因分布频率研究[J]. 现代医药卫生, 2014, 30(15): 2241-2245. [34] 徐丽娟, 卓海龙, 刘斌杰, 等. 血小板输注无效的临床分析[J]. 临床输血与检验, 2008, 10(1): 59-60. [35] Slichter SJ, Davis K, Enright H, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients[J]. Blood, 2005, 105( 10): 4106-4114. [36] 杨荨鲜, 唐万兵. 单采血小板输注无效18例临床观察[J].中国医药导报, 2010, 7(2): 28-29. [37] 于荣秀, 李萍, 李敬华, 等. 血液肿瘤患者机采血小板无效输注的临床分析[J]. 广东医学, 2009, 30(8): 1079-1080. [38] George JN, Raskob GE, Shah SR, et al. Drug-induced thrombocytopenia:a systematic review of published case reports[J]. Annals of internalmedicine, 1998, 129(11): 886-890. [39] 周欣华, 王小微, 林海玉. 血液病患者单采血小板输注的护理[J]. 护理学报, 2009, 16(11B): 28-29. [40] 王一, 王存彪. 血小板无效输注及治疗策略[J]. 国外医学输血及血液学分册, 2001, 24(4): 339-342. |